• Amikacin Disulfate: Applied Workflows for Antibiotic Mechani

  2026-07-16

  Amikacin disulfate enables precision dissection of antibiotic mechanisms and protein–antibiotic complexation workflows. This guide outlines experimental protocols, troubleshooting, and the latest insights from lysozyme interaction studies to help researchers overcome technical bottlenecks in antibiotic resistance research.

• Patient-Derived Gastric Cancer Assembloids Reveal Stromal Im

  2026-07-16

  This study presents a novel gastric cancer assembloid model that incorporates matched patient tumor organoids and stromal cell subpopulations, capturing microenvironment complexity often missing from traditional systems. The model demonstrates how stromal diversity shapes gene expression and drug response, advancing personalized medicine and drug resistance research.

• GSK J4 HCl: Potent JMJD3 Inhibitor for Epigenetic Research

  2026-07-15

  GSK J4 HCl is a selective, cell-permeable inhibitor of the H3K27 demethylase JMJD3, widely employed in epigenetic regulation research. It demonstrates robust inhibition of inflammatory cytokine production and has validated in vivo efficacy in tumor models, establishing it as a critical tool for investigating chromatin-mediated transcriptional control.

• Fluconazole: Evidence-Driven Guide to Antifungal Mechanism &

  2026-07-15

  Fluconazole is a triazole antifungal that inhibits the fungal cytochrome P450 enzyme 14α-demethylase, disrupting ergosterol biosynthesis and cell membrane integrity. This guide compiles atomic, verifiable facts on its mechanism, antifungal activity, and research applications, with protocol-ready parameters and clarifications on resistance limits.

• Patient-Derived Gastric Cancer Assembloids Enhance Drug Test

  2026-07-14

  Shapira-Netanelov et al. introduce a patient-derived gastric cancer assembloid model that integrates matched tumor organoids with stromal cell subpopulations, capturing the complexity of the tumor microenvironment. This approach enables robust analysis of drug responses and resistance mechanisms, advancing preclinical and personalized cancer research.

• Adefovir (GS-0393): Advanced Workflows in HBV Antiviral Rese

  2026-07-14

  Leverage Adefovir (GS-0393) for rigorous hepatitis B virus research and renal transporter assays with precision-guided protocols. This guide translates bench-top evidence and clinical insights into actionable workflows and troubleshooting strategies for reproducible, high-impact results.

• Sodium Overload Disrupts Mitochondrial Metabolism in NECSO

  2026-07-13

  Qiao et al. reveal that sodium influx via TRPM4 channels disrupts mitochondrial energy metabolism, executing necrosis by suppressing oxidative phosphorylation and the TCA cycle. This mechanistic insight into NECSO clarifies how ion imbalances drive cell death and highlights new directions for mitochondrial function analysis in disease contexts.

• Cyclic di-GMP: Applied Protocols for Biofilm and Immune Rese

  2026-07-13

  Cyclic di-GMP unlocks unique advantages for researchers probing biofilm formation and innate immune modulation. This article details how APExBIO’s high-purity Cyclic di-GMP empowers reproducible workflows, offers troubleshooting strategies, and translates the latest mechanistic insights into actionable protocols.

• Betaine Hydrochloride: Precision Reagent for Protease and Me

  2026-07-12

  Explore the molecular properties and advanced applications of Betaine hydrochloride in metabolic enzyme and protease research. This in-depth analysis provides unique, practical assay insights grounded in recent mechanistic discoveries.

• SB 202190: Protocols and Innovations in p38 MAP Kinase Inhib

  2026-07-10

  SB202190 (FHPI) is a benchmark p38 MAP kinase inhibitor enabling high-resolution dissection of inflammatory and apoptotic signaling. This article translates recent bench discoveries into robust, actionable workflows and troubleshooting strategies for inflammation research and cancer therapeutics.

• EdU Imaging Kits (Cy5): Precision Cell Proliferation Assays

  2026-07-09

  EdU Imaging Kits (Cy5) deliver high-sensitivity, morphology-preserving cell proliferation measurement by harnessing click chemistry for S-phase DNA synthesis detection. This workflow-centric guide translates recent single-cell cancer research into actionable protocols, troubleshooting strategies, and advanced applications—empowering researchers to surpass BrdU-based limitations.

• WEHI-539: BCL-XL Inhibitor for Advanced Apoptosis Research

  2026-07-09

  WEHI-539 is a benchmark BCL-XL inhibitor enabling precise dissection of apoptosis pathways and targeted sensitization of cancer stem cells. This guide delivers actionable workflow enhancements, troubleshooting insights, and protocol parameters drawn from leading studies and product expertise.

• USP42 Drives Breast Cancer Progression by Inhibiting JNK/p38

  2026-07-08

  This study identifies USP42 as a key promoter of breast cancer progression by suppressing JNK/p38-mediated apoptotic signaling. The findings highlight USP42's mechanistic role in modulating tumor cell survival and its potential as a therapeutic target in breast cancer.

• LLY-507: SMYD2 Inhibitor Workflows for Cancer & Fibrosis Res

  2026-07-08

  LLY-507 empowers translational researchers with potent, highly selective SMYD2 inhibition, enabling precise dissection of cancer cell proliferation and fibrosis mechanisms. Discover optimized experimental workflows and real-world troubleshooting that set LLY507 apart as an indispensable tool for oncology and renal disease models.

• G418 Sulfate (Geneticin): Precision Tools for Cell Selection

  2026-07-07

  G418 Sulfate (Geneticin) enables robust genetic engineering selection and delivers quantifiable antiviral performance, particularly in studies involving Dengue virus inhibition. Discover protocol enhancements, trouble-shooting strategies, and data-driven workflows that maximize the utility of this high-purity antibiotic from APExBIO.

16999 records 1/1134 page Next 12345 下5页 Last page